- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02711709
Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced Frailty
Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle: The Acute Development and Persistence of Frailty, Comorbidity and Disability in Critically Ill Patients After Intra-abdominal Sepsis "Induced Frailty
Study Overview
Status
Conditions
Detailed Description
This is a prospective study aimed at identifying the frequency, natural history and long term outcomes of CCI and PICS in the survivors of Intra-abdominal sepsis.
In addition to the in-hospital clinical data collected from the parent study, pre and post-sepsis measurements of frailty, comorbidity and disability will be obtained via questionnaires and the electronic health records. Frailty, comorbidity and disability assessments will also be completed at the three, six, and 12 month follow up assessments.
Frailty measures A frailty index will be determined as a combination of factors.
An older adult is considered physically vulnerable when they experience:
- muscle weakness
- fatigue
- low physical activity, and unintentional loss in body weight, which has been agreed upon by a consensus of experts.
Two additional non-intravenous contrasted CT scans will be obtained at 3 and 12 months as part of the study protocol to assess for interval change in SMI/sarcopenia.
Objective mobility and activity monitoring will be performed to supplement assessment of frailty and disability. Wearable monitors (similar in size and appearance to a "smart watch" have received significant attention because they offer minimal burden, objectivity, versatility and low cost for assessing activity and mobility patterns. The monitor is similar in shape and size to a standard wrist watch. Thus, it will have minimal burden to patients. Each monitor will be fitted on the wrist and worn for 24 hours a day, but can be quickly removed for medical procedures, patient care or hygiene needs. Patients will wear the monitor for their entire length of stay in the hospital. It will be removed at discharge. Post-discharge, patients will be sent a monitor to wear for up to 10 days at four different time points: 3 months, 6 months and 12 months post-discharge. If study subjects are hospitalized long enough that discharge is within 30 days of the 3 month follow up, the 1 month post discharge monitoring period will be deferred. Outcomes include steps per day, total movements per day, minutes being sedentary and minutes moving at various intensities (e.g. light, moderate and vigorous).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- UF Health at Shands Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admission to the surgery or trauma ICU where clinical care can be managed by surgical critical care guided by standard operating procedures.
- Age ≥18 years
- Diagnosis of sepsis, severe sepsis, or septic shock
- Entrance into the standard-of-care sepsis protocol
- Ability to obtain patient/legally authorized representative informed consent.
Exclusion Criteria:
- Significant traumatic brain injury (evidence of neurologic injury on CT scan and a best Glascow Coma Scale <8 within 24 hours of injury)
- Refractory shock (i.e., patients who die within 12 hours)
- Alternative or confounding diagnosis causing shock state (e.g., myocardial infarction or pulmonary embolus)
- Uncontrollable source of sepsis (e.g., irreversible disease state such as unresectable dead bowel),
- Patients deemed to be futile care or have advanced care directives limiting resuscitative efforts such as patient or patient's family who are not committed to aggressive management of the patient's condition. Expected lifespan of the patient is less than 3 months due to severe pre-existing comorbidities (ex. Recurrent, advanced or metastatic cancer).
- Severe Congestive Heart Failure (NY Heart Association Class IV)
- Child-Pugh Class C liver disease or pre-liver transplant.
- Known HIV infection with CD4 count<200 cells/mm3,
- Organ transplant recipient on immunosuppressive agents
- Known pregnancy
- Inability to obtain informed consent
- Prisoners
- Institutionalized patients
- Chemotherapy or radiotherapy within 30 days prior to sepsis
- Spinal cord injuries resulting in permanent sensory and/or motor deficits.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Intra-abdominal sepsis
Frailty measurements.
Modified Minnesota Leisure Time Activities.
Computed tomography morphometrics.
Mobility Monitors.
|
A frailty index will be determined as a combination of factors. An older adult is considered physically vulnerable when they experience:
This will be collected at baseline, 3, 6 and 12 months.
A questionnaire used to assess physical activity will be administered at baseline, 3, 6 and 12 months.
A CT scan will occur as standard of care while the patient is hospitalized.
Two additional CT scans will occur at 3 and 12 months to assess for sarcopenia.
Mobility monitors will be placed on the patients during the duration of their hospital stay.
They will then where them at 3, 6 and 12 months for up to 10 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
A change in rate of participants (0-100%) that meet frailty consensus criteria comparing baseline score to assessments after (3, 6, 12 months) episode of intra-abdominal sepsis using the Fried Frailty Criteria.
Time Frame: Baseline, 3, 6 and 12 months.
|
1. Fried Frailty Criteria: Possible score of 0-5 based on clinical criteria.
Score of 0 = "Not Frail", Score of 1-2 = "pre-frail", score ≥3 = "Frail".
Integer score, no units of measures
|
Baseline, 3, 6 and 12 months.
|
A change in rate of participants (0-100%) that meet frailty consensus criteria comparing baseline score to assessments after (3, 6, 12 months) episode of intra-abdominal sepsis using the Rockwood Frailty Criteria.
Time Frame: Baseline, 3, 6 and 12 months.
|
Rockwood Frailty Criteria: Ratio (0-1.0) based on number of positive clinical factors of a 70 item list of clinical deficits (i.e.
7/70 deficits = 0.1).
Ratio score, no units of measure.
|
Baseline, 3, 6 and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in measurement of torso sarcopenia.
Time Frame: Baseline, 3, 6 and 12 months.
|
Sarcopenia as measured by computed tomography morphometric analysis calculation of skeletal muscle index (SMI) at the level of the 3rd lumbar vertebra at baseline as compared to 3 and 6 months after intra-abdominal sepsis.
Sarcopenia is defined as SMI ≤38.5 cm2/m2 for men and ≤52.4 cm2/m2.
|
Baseline, 3, 6 and 12 months.
|
A change in the Modified Minnesota leisure time activities questionnaire from baseline to the one year mark.
Time Frame: Baseline, 3, 6 and 12 month
|
This measures leisure time (both free time and domestic chores) for the 2 weeks prior to the hospitalization and at each of the above referenced time points.
The raw scores are indexed to a key of activity and intensity codes, which are then utilized to calculate an Activity Metabolic Index.
A healthy AMI will have an intensity code of 6.0 while a fight AMI will have intensity codes of 4.0 or less.
|
Baseline, 3, 6 and 12 month
|
A change in mobility and activity from hospitalization to the one year mark.
Time Frame: Baseline, 3, 6 and 12 months.
|
This is measured as total movements per day (integer, no units of measure) and steps per day (integer, no units of measure) by portable actigraphy monitors as measured during inpatient hospitalization as compared to 1-week assessments at 3, 6 and 12 months after intra-abdominal sepsis.
These measurements will be aggregated and then classified by an overall intensity index (light, moderate, vigorous).
|
Baseline, 3, 6 and 12 months.
|
Mortality
Time Frame: Up to one year
|
Mortality will be assessed daily while the subject is in the hospital and then at post discharge follow up visits or by phone if the subject is unable to come to the follow up appointments.
The Social Security mortality database will be accessed for subjects that are lost to follow up.
|
Up to one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Philip Efron, MD, University of Florida
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201501027-N
- P30AG028740 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Zagazig UniversityRecruitingSepsis-associated EncephalopathyEgypt
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
Clinical Trials on Frailty Measurements
-
Diskapi Yildirim Beyazit Education and Research...Recruiting
-
Anhui Provincial HospitalNot yet recruitingQuality of Life | Prostatic Neoplasms | Frailty | Survival | Blood Biological Indicators
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, Caen; University Hospital, LilleCompleted
-
Hospital Universitario GetafeKarolinska Institutet; Medical University of Lodz; Universidad Politecnica de... and other collaboratorsUnknownFrail Elderly Syndrome | Frailty | Frailty SyndromePoland, Spain, Sweden
-
Population Health Research InstituteRecruitingGynecologic Cancer | Frailty | OncologyCanada
-
Methodist Health SystemCompleted
-
Weidong MiCompleted
-
University Hospital of FerraraCompleted
-
German Heart InstituteThe German Heart FoundationUnknown
-
Kochi UniversityRecruiting